Clinical and Experimental Dermatology

Article	Citations
Erythema multiforme‐like eruption in patients with COVID‐19 infection: clinical and histological findings	111
Two cases of COVID‐19 presenting with a clinical picture resembling chilblains: first report from the Middle East	100
Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital	88
Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice	54
COVID‐19 vaccine‐induced Stevens–Johnson syndrome	53
WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID‐19): from bedside to phone‐side	52
Skin manifestations of COVID‐19 in children: Part 1	52
Treatment options for leishmaniasis	51
Reduction in skin cancer diagnoses in the UK during the COVID‐19 pandemic	45
Potential use of turmeric in COVID‐19	42
Irritant contact dermatitis in healthcare workers as a result of the COVID‐19 pandemic: a cross‐sectional study	39
A cutoff value for the Systemic Immune‐Inflammation Index in determining activity of Behçet disease	39
De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine	38
Janus kinase inhibitors for atopic dermatitis: a promising treatment modality	38
COVID‐19 vaccination and patients with psoriasis under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers	38
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID‐19 vaccine	38
Skin manifestations of COVID‐19 in children: Part 2	36
Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination	35
Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance	34
Facial dermatoses in the general population due to wearing of personal protective masks during the COVID‐19 pandemic: first observations after lockdown	34
Line‐field optical coherence tomography: in vivo diagnosis of basal cell carcinoma subtypes compared with histopathology	33
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’	33
Telemedicine and support groups could be used to improve adherence to treatment and health‐related quality of life in patients affected by inflammatory skin conditions during the COVID‐19 pandemic	31
The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience	31
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns	30

Chilblain‐like lesions: a case series of 41 patients during the COVID‐19 pandemic	29
Line‐field confocal optical coherence tomography for actinic keratosis and squamous cell carcinoma: a descriptive study	28
Successful treatment with dupilumab of an adult with Netherton syndrome	27
Reactive infectious mucocutaneous eruption: Mycoplasma pneumoniae ‐induced rash and mucositis and other parainfectious eruptions	27
Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?	27
A flare of pre‐existing erythema multiforme following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccine	26
Novel targets and therapies for keloid	26
Patient satisfaction with a new skin cancer teledermatology service	25
Skin manifestations of COVID‐19 in children: Part 3	24
Pityriasis rubra pilaris‐like eruption following administration of the BNT163b2 (Pfizer–BioNTech) mRNA COVID‐19 vaccine	23
Performance of ChatGPT on Specialty Certificate Examination in Dermatology multiple-choice questions	23
Management of nail psoriasis	23
Skin signs resembling vascular acrosyndromes during the COVID‐19 outbreak in Italy	22
Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab	22
Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature	22
Clinical characteristics and disease burden in prurigo nodularis	22
Associations of particulate matter with atopic dermatitis and chronic inflammatory skin diseases in South Korea	21
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic	21
Tofacitinib for the treatment of refractory pyoderma gangrenosum	21
Dermatological effects of Curcuma species: a systematic review	21
Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics	21
Merkel cell carcinoma	21
Successful use of guselkumab in the treatment of severe hidradenitis suppurativa	21
Cutaneous manifestations in COVID‐19: familial cluster of urticarial rash	20
Recognizable vascular skin manifestations of SARS‐CoV‐2 (COVID‐19) infection are uncommon in patients with darker skin phototypes	19
COVID‐19‐associated herpetic gingivostomatitis	19
Novel outbreak of acral lesions in times of COVID‐19: a description of 74 cases from a tertiary university hospital in Spain	19
Vitiligo: an update on systemic treatments	19
Anifrolumab for treatment of refractory cutaneous lupus erythematosus	19
Sex‐ and gender‐associated clinical and psychosocial characteristics of patients with psoriasis	19
Real‐life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2‐year period	18
TikTok™ and dermatology: promises and pearls	18
Comorbidities of alopecia areata: a population‐based cohort study	18
Radiation recall dermatitis triggered by inactivated COVID‐19 vaccine	18
Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review	18
Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination	17
Observations about sexual and other routes of SARS‐CoV‐2 (COVID‐19) transmission and its prevention	16
Effect of biologics targeting interleukin‐23/‐17 axis on subclinical atherosclerosis: results of a pilot study	16
Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo	16
Capillary malformation−arteriovenous malformation syndrome: a multicentre study	16
COVID‐19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast	16
Mask‐induced dermatoses during the COVID‐19 pandemic: a questionnaire‐based study in 12 Korean hospitals	15
Impact of COVID‐19 on Mohs micrographic surgery: UK‐wide survey and recommendations for practice	15
Learning new ways of teaching and assessment: the impact of COVID‐19 on undergraduate dermatology education	15
TikTok™ and dermatology: lessons for medical education	15
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients	15
Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot st	15
Comment on ‘Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital’. Pseudoherpetic Grover disease seems to occur in patients with COV	15
Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia	15
Scratching damages tight junctions through the Akt–claudin 1 axis in atopic dermatitis	15

Successful treatment of recalcitrant nodular prurigo with tofacitinib	15
Interleukin‐9 serves as a key link between systemic inflammation and angiogenesis in psoriasis	14
Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination	14
Environmentally sustainable dermatology	14
COVID‐19‐induced toxic epidermal necrolysis	14
Ribonucleic acid COVID‐19 vaccine‐associated cutaneous adverse drug events: a case series of two patients	14
A clinical review and history of pubic lice	14
Primary cutaneous anaplastic large‐cell lymphoma: a review of the SEER database from 2005 to 2016	13
Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity	13
Childhood rosacea and related disorders	13
Symmetrical drug‐related intertriginous and flexural exanthema like eruption associated with COVID‐19 vaccination	13
The fate of major dermatology conferences and meetings of 2020: are e‐conferences and digital learning the future?	13
De novo subacute cutaneous lupus erythematosus‐like eruptions in the setting of programmed death‐1 or programmed death ligand‐1 inhibitor therapy: clinicopathological correlation	13
Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series	13
A targeted response to the COVID‐19 pandemic: analysing effectiveness of remote consultations for triage and management of routine dermatology referrals	13
Linear IgA bullous dermatosis following Oxford AstraZeneca COVID‐19 vaccine	13
Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab	13
The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis	13
Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis	13
Remote consultations for patients with hidradenitis suppurativa during the COVID‐19 pandemic: a single‐centre experience	12
MABp1 targeting interleukin‐1α in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open‐label extension period	12
Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant	12
Surgical plume in dermatology: an insidious and often overlooked hazard	12
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role?	12
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study	12
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation	12
Allergic and cutaneous reactions following inactivated SARS‐CoV‐2 vaccine (CoronaVac ® ) in healthcare workers	12
Severe cutaneous adverse reaction following COVID‐19 vaccination and immunotherapy: a second hit?	12
Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis	12
Ketoconazole 2% cream alters the skin fungal microbiome in seborrhoeic dermatitis: a cohort study	11
Porocarcinoma: a review	11
Successful use of tofacitinib in epidermolysis bullosa pruriginosa	11
Clascoterone as a novel treatment for androgenetic alopecia	11
Hydroquinone: myths and reality	11
Acne treatments: future trajectories	11
ChatGPT-3.5 and ChatGPT-4 dermatological knowledge level based on the Specialty Certificate Examination in Dermatology	11
Perceptions of the use of artificial intelligence in the diagnosis of skin cancer: an outpatient survey	10
Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug‐resistance testing in leprosy?	10
Establishing the efficacy and safety of the novel use of common salt for the treatment of pyogenic granuloma	10
A UK‐wide survey looking at teaching and trainee confidence in teledermatology: a vital gap in a COVID‐19‐induced era of rapid digital transformation?	10
Dermoscopic features and screening strategies for the detection of small‐diameter melanomas	10
Treatment of pemphigoid gestationis with dupilumab	10
Quality of life and sexuality in women with lichen sclerosus: a cross‐sectional study	10
Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology	10
Comparison of transepidermal water loss and skin hydration in diabetics and nondiabetics	10
Structural and functional differences in skin of colour	10
Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa	10
Successful treatment of dermatomyositis and associated calcinosis with adalimumab	10
Spironolactone in dermatology: uses in acne and beyond	9
Successful treatment of trichothiodystrophy with dupilumab	9
Usefulness of high‐frequency ultrasonography in the evaluation and monitoring of sclerosing dermatoses: a cohort study	9
Unleashing carbon emissions savings with regular teledermatology clinics	9
Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib	9
A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis	9
Melanoma defies ‘lockdown’: ongoing detection during Covid‐19 in central London	9
Segmental stiff skin syndrome: a novel case with an interleukin‐17C mutation successfully treated with secukinumab	9
Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis	9
Assessment of inter‐rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography	9
Mental health and dermatology practice in the COVID‐19 pandemic	9
Pyridoxine for prevention of hand–foot syndrome caused by chemotherapy agents: a meta‐analysis	9
Apremilast in benign chronic pemphigus (Hailey–Hailey disease)	9
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results	9
Teledermoscopy as a community based diagnostic test in the era of COVID‐19?	9
Acute urticaria alone after CoronaVac COVID-19 vaccination should not be a contraindication for revaccination	9
Long‐term antibiotic use for the treatment of hidradenitis suppurativa consistent with guideline recommendations	9
Shaping the future of teledermatology: a literature review of patient and provider satisfaction with synchronous teledermatology during the COVID-19 pandemic	9
Drug‐induced alopecia areata?	9
Comment on ‘ De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine’: possible role for Type I interferons	8
Erythema annulare centrifugum induced by COVID‐19 vaccination	8
Severe atopic dermatitis treated successfully with dupilumab throughout pregnancy	8
The impact of COVID‐19 on dermatology outpatient services in England in 2020	8
Male genital lichen sclerosus associated with urological interventions and microincontinence: a case series of 21 patients	8
Psoriasis and osteoporosis: a literature review	8
Probiotics in hidradenitis suppurativa: a potential treatment option?	8
A Piez-o the jigsaw: the Piezo1 channel in skin biology	8
COVID‐19: challenges and solutions for the future of UK dermatology undergraduate curriculum delivery	8
Slack as a virtual undergraduate dermatology community: a pilot study	8
Cost-effectiveness of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris	8
Classification of aplasia cutis congenita: a 25‐year review of cases presenting to a tertiary paediatric dermatology department	8
Malignancy and infection risk during adalimumab therapy in hidradenitis suppurativa	8

Effects of systemic therapies on pruritus in adults with atopic dermatitis: a systematic review and meta-analysis	8
In vitro survival of scabies mites	8
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on ‘Paradoxical hidradenitis suppurativa due to anti-int	8
Clinical phenotypes and therapeutic responses in cutaneous‐predominant sarcoidosis: 6‐year experience in a tertiary referral service	8
Chronic urticaria in the real‐life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study	8
Effects of the COVID‐19 pandemic on head lice and scabies infestation dynamics: a population‐based study in France	8
Monkeypox: key pointers for dermatologists	8
Evaluation of the Dermatological Life Quality Index, sexual dysfunction and other psychiatric diseases in patients diagnosed with vitiligo with and without genital involvement	8
Scratching the surface: a review of online misinformation and conspiracy theories in atopic dermatitis	8
Analysis of the first 5 years of an interdisciplinary Rheumatology–Dermatology clinic	8
Comment on ‘Two cases of COVID‐19 presenting with a clinical picture resembling chilblains: first report from the Middle East’: pernio unrelated to COVID‐19	8
Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single‐centre randomized evaluator‐blinded clinical and in vitro studies in norma	8
Delayed localized hypersensitivity reactions to COVID‐19 mRNA vaccines: a 6‐month retrospective study	8
Refractory Type I pityriasis rubra pilaris treated with tildrakizumab	8
Ultraviolet radiation‐induced degradation of dermal extracellular matrix and protection by green tea catechins: a randomized controlled trial	8
News on infantile haemangioma. Part 1: clinical course and pathomechanism	7
Combination dermoscopy highlights fungal invasion of vellus hair in tinea vellus	7
Anakinra for recalcitrant pyoderma gangrenosum	7
Clinical presentation, sonographic features and treatment options of segmental stiff skin syndrome	7
Psychosocial burden and out‐of‐pocket costs in patients with atopic dermatitis in Ireland	7
Male genital lichen sclerosus, microincontinence and occlusion: mapping the disease across the prepuce	7
Dermatological surgery: an update on suture materials and techniques. Part 1	7
Genes and phenotypes in vascular malformations	7
Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation	7
Palmar digital vein thrombosis in a patient with COVID‐19	7
Paradoxical eczema in patients with psoriasis receiving biologics: a case series	7
Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36‐month follow‐up study	7
Serum tryptase levels in patients with psoriasis: a pilot study for a possible useful biomarker	7
Reporting regression in primary cutaneous melanoma. Part 1: history, histological criteria and pathogenesis	7
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib	7
Potentiating cutaneous wound healing in young and aged skin with nutraceutical collagen peptides	7
Comment on ‘Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?’: Type I interferons as possible link between COVID‐19 vaccine and vitiligo	7
Topical timolol in dermatology: infantile haemangiomas and beyond	7
Immune response to SARS-CoV-2 mRNA vaccine in patients with psoriasis treated with biologics	7
Fast‐tracking teledermatology into dermatology trainee timetables, an overdue necessity in the COVID era and beyond	7
A paradigm shift in trainee confidence in teledermatology and virtual working during the COVID‐19 pandemic: results of a follow‐up UK‐wide survey	7
Evaluation of serum cardiac troponin I and N‐terminal pro‐B‐type natriuretic peptide levels in patients with alopecia areata	7
Improvement of Hailey–Hailey disease with abrocitinib	7
The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?	7
Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data	7
Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population	7
Identification of putative genetic modifying factors that influence the development of Papillon–Lefévre or Haim–Munk syndrome phenotypes	7
Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow‐up	7
Reporting regression in primary cutaneous melanoma. Part 2: prognosis, evaluation and management	7
Patient perceptions of Mohs micrographic surgery during the COVID‐19 pandemic and lessons for the next outbreak	7
Prevalence of hidradenitis suppurativa in Malta: comparison with established epidemiological data	7
A novel c.671_682del NCSTN variant in a family with hidradenitis suppurativa: a pilot study	7
Favipiravir‐induced cutaneous adverse reactions in patients infected with COVID‐19	7
Vogt–Koyanagi–Harada‐like syndrome in the setting of combined anti‐PD1/anti‐CTLA4 therapy	7
#corticophobia: a review on online misinformation related to topical steroids	7
Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: a case report and literature review	7
Co‐occurrence of Aicardi–Goutières syndrome type 6 and dyschromatosis symmetrica hereditaria due to compound heterozygous pathogenic variants in ADAR1 : a case series fr	7
TikTok™, teens and isotretinoin: recommendations for identifying trending acne‐related content on the world’s most popular social media platform	6
Taipan snake venom time for antiphospholipid syndrome solves a 20‐year diagnostic challenge	6
Successful use of baricitinib in the treatment of refractory rheumatoid arthritis‐associated Sweet syndrome	6
Dupilumab unmasking cutaneous T‐cell lymphoma: report of a fatal case	6
Acne and rosacea in skin of colour	6
Amyloidosis in hidradenitis suppurativa: a cross‐sectional study and review of the literature	6
Association of prurigo nodularis and infectious disease hospitalizations: a national cross‐sectional study	6
Isotretinoin on TikTok™: misinformation getting under our skin	6
Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross‐sectional, multicentre study of 263 patients	6
Rapid and sustained response to spesolimab in five Chinese patients with generalized pustular psoriasis	6
Skin lightening: causes and complications	6
High‐dose bilastine for the treatment of BASCULE syndrome	6
A novice's guide to qualitative health professions education research	6
Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies	6
The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository	6
Differential diagnosis and management of hyperpigmentation	6
Shades of grey: what is paediatric psoriasiform dermatitis and what does it have in common with childhood psoriasis?	6
Cigarette smoking and risk of herpes zoster: a population‐based cohort study in Taiwan	6
The British Association of Dermatologists’ Undergraduate Curriculum Update 2021	6
Vogt–Koyanagi–Harada‐like syndrome induced by immune checkpoint inhibitors in a patient with melanoma	6
Laser therapy is a safe and effective treatment for unwanted hair in adults undergoing male to female sex reassignment	6
The human microbiome in immunobullous disorders and lichen planus	6
An analysis of qualitative responses from a UK survey of the psychosocial wellbeing of people with skin conditions and their experiences of accessing psychological support	6
Direct immunofluorescence findings in livedoid vasculopathy: a 10‐year study and literature review	6
Ocular and auditory abnormalities in patients with vitiligo: a case–control study	6
Exploring the implications of the first COVID‐19 lockdown on patients with melanoma: a national survey	6
Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab	6
Depression in transgender adolescents under treatment with isotretinoin	6
Off‐label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series	6
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group	6
Inpatient teledermatology improves diagnostic accuracy and management of erythroderma in hospitalized patients	6
The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL‐1 cell growth	6
Panton–Valentine leucocidin-producing Staphylococcus aureus: a clinical review	6
	6
BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies	6
UK‐based dermatologist online survey on the current practice and training in the management of melasma and postinflammatory hyperpigmentation	6
Genetic analysis in three Egyptian patients with Griscelli syndrome Type 1 reveals new nonsense mutations in MYO5A	6
Menopause, skin and common dermatoses. Part 1: hair disorders	6
Clinical and histopathological features of adult patients with dermatomyositis and melanoma differentiation associated‐5 autoantibody seropositivity status, as determined by commercially available tes	6
Secure communication conduits during COVID‐19 lockdown	6
Dermatological insights from Google Trends: what does the public think is important during COVID‐19 lockdown?	6
Super‐high magnification dermoscopy can aid the differential diagnosis between melanoma and atypical naevi	6
UK psychodermatology services in 2019: service provision has improved but is still very poor nationally	6